Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Net Loans Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

DarioHealth (DRIO) Change in Acquisitions & Divestments (2017 - 2023)

DarioHealth filings provide 6 years of Change in Acquisitions & Divestments readings, the most recent being $4.3 million for Q2 2023.

On a quarterly basis, Change in Acquisitions & Divestments changed N/A to $4.3 million in Q2 2023 year-over-year; TTM through Dec 2023 was $5.0 million, a N/A change, with the full-year FY2023 number at $5.0 million, changed N/A from a year prior.
Change in Acquisitions & Divestments hit $4.3 million in Q2 2023 for DarioHealth, up from $708000.0 in the prior quarter.
In the past five years, Change in Acquisitions & Divestments ranged from a high of $4.3 million in Q2 2023 to a low of $1000.0 in Q2 2019.